James M. Hinson
Corporate Officer/Principal bij Unicorn Pharma Consulting, Inc.
Actieve functies van James M. Hinson
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| Unicorn Pharma Consulting, Inc. | Corporate Officer/Principal | 06-11-2009 | - |
Loopbaan van James M. Hinson
Eerdere bekende functies van James M. Hinson
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
Aldagen, Inc.
 Aldagen, Inc. Pharmaceuticals: GenericHealth Technology Aldagen, Inc. develops and produces pharmaceutical products. It focuses on developing product candidates to address cardiovascular disease. The firm develops ALD-301 for the treatment of critical limb ischemia; ALD-201 for the treatment of ischemic heart failure; and ALD-401 for the post-acute treatment of ischemic stroke. The company also supplies ALDHbr cells for use in investigator-sponsored clinical studies. Aldagen was founded by Andrew E. Balber, Michael Sherman Colvin, Clay Smith and Nelson Chao in March 2000 and is headquartered in Durham, NC. | Hoofd Techniek/Wetenschap/O&O | 06-11-2009 | - |
| Corporate Officer/Principal | 06-11-2009 | 06-11-2009 |
Opleiding van James M. Hinson
| University of Missouri | Undergraduate Degree |
| Vanderbilt University | Doctorate Degree |
Statistieken
Internationaal
| Verenigde Staten | 5 |
Operationeel
| Corporate Officer/Principal | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
| Undergraduate Degree | 1 |
Sectoraal
| Consumer Services | 3 |
| Health Technology | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
Aldagen, Inc.
Aldagen, Inc. Pharmaceuticals: GenericHealth Technology Aldagen, Inc. develops and produces pharmaceutical products. It focuses on developing product candidates to address cardiovascular disease. The firm develops ALD-301 for the treatment of critical limb ischemia; ALD-201 for the treatment of ischemic heart failure; and ALD-401 for the post-acute treatment of ischemic stroke. The company also supplies ALDHbr cells for use in investigator-sponsored clinical studies. Aldagen was founded by Andrew E. Balber, Michael Sherman Colvin, Clay Smith and Nelson Chao in March 2000 and is headquartered in Durham, NC. | Health Technology |
| Unicorn Pharma Consulting, Inc. |
- Beurs
- Insiders
- James M. Hinson
- Ervaring
